ReviewPostgraduate medicine2022
Potential neurological manifestations of COVID-19: a narrative review.
Review in Postgraduate medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 31 citations in OpenAlex.
- Significance of Neurological Manifestations and Their Association With Clinical Outcomes in Hospitalized COVID-19 Patients in Bandar Abbas, Iran: A Cross-Sectional Study.Health science reports · 2025Article
- MRI evidence of gray matter loss in COVID-19 patients with cognitive and olfactory disorders.Annals of clinical and translational neurology · 2024Article
- Protocol for a systematic review to understand the long-term mental-health effects of influenza pandemics in the pre-COVID-19 era.Scandinavian journal of public health · 2024Article
- Balance Ability and Quality of Life in Older Adult with Recovery from Mild COVID-19.Annals of geriatric medicine and research · 2023Article
- Article
- The impact of COVID-19 on chronic pain.Frontiers in pain research (Lausanne, Switzerland) · 2023Review
- Cranial nerve involvement among COVID-19 survivors.Frontiers in neurology · 2023Article
- Postural balance and its association with functionality and quality of life in non-hospitalized patients with post-acute COVID-19 syndrome.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2022Article
- Article
- COVID-19 and micronutrient deficiency symptoms - is there some overlap?Clinical nutrition ESPEN · 2022Review
- Review
- Occupational and Physical Therapy Strategies for the Rehabilitation of COVID-19-Related Guillain-Barré Syndrome in the Long-term Acute Care Hospital Setting: Case Report.JMIR rehabilitation and assistive technologies · 2022Article
- Review
- Updates on Palliative Medicine in the COVID-19 Era.Journal of clinical medicine · 2022Article
- Post-COVID-19 conditions in Ecuadorian patients: an observational study.Lancet regional health. Americas · 2022Article
- Electrodiagnostic findings in COVID-19 patients: A single center experience.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2021Observational
- Analgesic Drugs and COVID-19.Journal of clinical medicine · 2021Article
- Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus-2.Ibrain · 2021Review
- Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?Biology direct · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 7 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurological manifestations are increasingly reported in a subset of COVID-19 patients. Previous infections related to coronaviruses, namely Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS) also appeared to have neurological effects on some patients. The viruses associated with COVID-19 like that of SARS enters the body via the ACE-2 receptors in the central nervous system, which causes the body to balance an immune response against potential damage to nonrenewable cells. A few rare cases of neurological sequelae of SARS and MERS have been reported. A growing body of evidence is accumulating that COVID-19, particularly in severe cases, may have neurological consequences although respiratory symptoms nearly always develop prior to neurological ones. Patients with preexisting neurological conditions may be at elevated risk for COVID-19-associated neurological symptoms. Neurological reports in COVID-19 patients have described encephalopathy, Guillain-Barré syndrome, myopathy, neuromuscular disorders, encephalitis, cephalgia, delirium, critical illness polyneuropathy, and others. Treating neurological symptoms can pose clinical challenges as drugs that suppress immune response may be contraindicated in COVID-19 patients. It is possible that in some COVID-19 patients, neurological symptoms are being overlooked or misinterpreted. To date, neurological manifestations of COVID-19 have been described largely within the disease trajectory and the long-term effects of such manifestations remain unknown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.